Diabetes Mellitus and Heart Failure.

This difference may not be significant in clinical practice, since patients at high risk of cardiorenal disease should be treated with SGLT-2i or GLP1-RA independent of HbA1c, and most patients with T2DM rapidly require combination therapy [ 105 ].

also in 2,774 other papers